Jardiance (empagliflozin) is the newest member of the new class of diabetes medication called SGL2 Inhibitors. This class of medications works by eliminating excess blood glucose through the urine.
A recent review in June 2016 by the United States’ Food and Drug Administration (FDA) Advisory Committee voted that there was substantial evidence to support Jardiance (empagliflozin)’s benefits in cardiovascular (CV) diseases. The FDA’s Advisory Committee consisted of specialists and experts in endocrinology and metabolism. The evidence reviewed was mainly based on results from the large-scale, multi-national clinical trial published in 2015 called the EMPA-REG OUTCOME trial. (click to read details about the FDA Advisory Committee’s Review)
The EMPA-REG OUTCOME trial was a long-term, multi-center, randomized, double-blind, placebo-controlled trial involving over 7,000 patients from 42 countries, with type 2 diabetes (T2D) and cardiovascular (CV) disease. The study assessed the effect of Jardiance (empagliflozin) 10mg or 25mg once daily versus placebo added to the standard baseline therapy for diabetes and cardiovascular disease. The results showed that over a median of 3.1 years, Jardiance (empagliflozin) compared to placebo, significantly reduced the risk of CV death, non-fatal heart attack or non-fatal stroke by 14 percent. The risk of CV death alone was reduced by 38 percent. (click to read the EMPA-REG OUTCOME trial)
Jardiacne (empagliflozin) is the only diabetes medication that has demonstrated significant benefits for CV disease. Since publication of the EMPA-REG OUTCOME trial, Jardiance (empagliflozin) has quickly became the preferred drug of choice with many specialists in cardiology and endocrinology for patients with diabetes and CV disease. The review by the FDA Advisory Committee approved the official expansion for the indication of Jardiance (empagliflozin) to be used in managing CV disease.
The price of Jardiance is approximately $500 per month in the United States. With its growing demand, we are receiving a lot of inquiries and helped many patients buy Jardiance (empagliflozin) at affordable prices. Please do not hesitate to contact our licensed and experienced pharmacists toll-free (1-888-488-9965) for a free consultation regarding your health care and medication needs.